NCT05299073View on ClinicalTrials.gov

A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva

PHASE1CompletedINTERVENTIONAL
Enrollment

257

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

March 18, 2023

Study Completion Date

March 18, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

MB09

Single dose of 35mg SC administered

DRUG

US-sourced Xgeva

Single dose of 35mg SC administered

DRUG

EU-sourced Xgeva

Single dose of 35mg SC administered

Trial Locations (1)

Unknown

Biokinetica - Early Phase Institute, Józefów

All Listed Sponsors
lead

mAbxience Research S.L.

INDUSTRY